Literature DB >> 21296037

Quantification of triamcinolone acetonide in ocular tissues after intravitreal injection to rabbit using liquid chromatography-tandem mass spectrometry.

Shuang-Qing Zhang1.   

Abstract

A sensitive and selective liquid chromatographic-tandem mass spectrometric method was developed for quantification of triamcinolone acetonide (TA) in rabbit ocular tissues. After a simple liquid-liquid extraction using tert-butyl methyl ether, TA and internal standard methylprednisolone were separated on a C₁₈ column with a mobile phase of acetonitrile:water:formic acid (60:40:0.1, v/v/v) and quantified by the use of selected reaction monitoring mode with a total run time of 4 min. The method was validated in tissue homogenates with a daily working range of 1-1000 ng/mL with correlation coefficient of more than 0.99 and a sensitivity of 1 ng/mL as lower limit of quantification, respectively. The mean intra-day and inter-day precisions were less than 10% and accuracy values were higher than 90%. This method was fully validated for the accuracy, precision and stability studies. The method proved to be accurate and specific, and was applied to an in vivo biodistribution study of TA after intravitreal injection to rabbits. Values of mean residence time in vitreous humor, crystalline lens and aqueous humor were 27.7, 35.8 and 20.0 days, respectively.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296037     DOI: 10.1016/j.jchromb.2011.01.012

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  2 in total

1.  Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits.

Authors:  You-Fan Ye; Yong-Feng Gao; Hua-Tao Xie; Hai-Jun Wang
Journal:  Mol Vis       Date:  2014-05-13       Impact factor: 2.367

2.  Pharmacokinetics after Periocular Methylprednisolone Sodium Succinate Injection in Rabbit Eyes.

Authors:  Hua-Yi Lu; Rui-Qing Wang; Xin Li; Xu Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-27       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.